Basic Information
| RNALocate ID: | RLID-D:11000489 |
| RNA Symbol: | hsa-miR-512-3p |
| Localization: | Microvesicle |
RNA Information
| RNA Name: | hsa-miR-512-3p |
| RNA ID: | miRBase:MIMAT0002823 |
| RNA Category: | miRNA |
| Species: | Homo sapiens |
Localization Information
| Tissue/Cell Line: | Fibroblasts |
| Database: | EVmiRNA |
Other Subcellular Localization
| RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
| RLID:11003024 | Exosome | Brain tissue | 23382797 |
| RLID-D:11001252 | Exosome | Breast milk|Cell lines|Epididymal epithelial cells|Osteoblast|Plasma|Primary glioblastoma neurosphere cells|Primary keratinocyte|Saliva|Serum|Urine |
ncRNA Disease Information
| Resource | RNA Symbol | Disease | Link |
| MNDR | hsa-miR-512-3p | Oral squamous cell carcinoma | MNDR-E-MI-56559 |
| MNDR | hsa-miR-512-3p | Non-hodgkin lymphoma | MNDR-E-MI-56560 |
| MNDR | hsa-miR-512-3p | Estrogen-receptor positive breast cancer | MNDR-E-MI-56561 |
| MNDR | hsa-miR-512-3p | Estrogen-receptor negative breast cancer | MNDR-E-MI-56562 |
| MNDR | hsa-miR-512-3p | Progesterone-receptor positive breast cancer | MNDR-E-MI-56563 |
| MNDR | hsa-miR-512-3p | Progesterone-receptor negative breast cancer | MNDR-E-MI-56564 |
| MNDR | hsa-miR-512-3p | Her2-receptor positive breast cancer | MNDR-E-MI-56565 |
| MNDR | hsa-miR-512-3p | Dermatomyositis | MNDR-E-MI-56566 |
| MNDR | hsa-miR-512-3p | Prostate cancer | MNDR-E-MI-56567 |
| MNDR | hsa-miR-512-3p | Gastric cancer | MNDR-E-MI-56568 |
| MNDR | hsa-miR-512-3p | Lung cancer | MNDR-E-MI-56569 |
| MNDR | hsa-miR-512-3p | Parkinson disease | MNDR-E-MI-56570 |
| MNDR | hsa-miR-512-3p | Breast cancer | MNDR-E-MI-56571 |
| MNDR | hsa-miR-512-3p | Pancreatic cancer | MNDR-E-MI-56572 |
| MNDR | hsa-miR-512-3p | Melanoma | MNDR-E-MI-56573 |
| MNDR | hsa-miR-512-3p | Nephroblastoma | MNDR-E-MI-56574 |
| MNDR | hsa-miR-512-3p | Colon cancer | MNDR-E-MI-56575 |
| MNDR | hsa-miR-512-3p | Relapsing-remitting multiple sclerosis | MNDR-E-MI-56576 |
| MNDR | hsa-miR-512-3p | Familial ovarian cancer | MNDR-E-MI-56577 |
| MNDR | hsa-miR-512-3p | Malignant glioma | MNDR-E-MI-56578 |
| MNDR | hsa-miR-512-3p | Amyotrophic lateral sclerosis | MNDR-E-MI-56579 |
| MNDR | hsa-miR-512-3p | Liposarcoma | MNDR-E-MI-56580 |
| MNDR | hsa-miR-512-3p | Inclusion body myositis | MNDR-E-MI-56581 |
| MNDR | hsa-miR-512-3p | Middle cerebral artery infarction | MNDR-E-MI-56582 |
| MNDR | hsa-miR-512-3p | Carcinoma lung non-small-cell | MNDR-E-MI-56583 |
| MNDR | hsa-miR-512-3p | Lung adenocarcinoma | MNDR-E-MI-56584 |
| MNDR | hsa-miR-512-3p | Bladder urothelial carcinoma | MNDR-E-MI-56585 |
| MNDR | hsa-miR-512-3p | Pancreatic adenocarcinoma | MNDR-E-MI-56586 |
| MNDR | hsa-miR-512-3p | Cholangiocarcinoma | MNDR-E-MI-56587 |
| MNDR | hsa-miR-512-3p | Esophageal cancer | MNDR-E-MI-56588 |
| MNDR | hsa-miR-512-3p | Hepatocellular carcinoma | MNDR-E-MI-56589 |
| MNDR | hsa-miR-512-3p | Embryonal cancer | MNDR-E-MI-56590 |
| MNDR | hsa-miR-512-3p | Familiar ovarian carcinoma | MNDR-E-MI-56591 |
| MNDR | hsa-miR-512-3p | B-cell non-hodgkin lymphoma | MNDR-E-MI-56592 |
| MNDR | hsa-miR-512-3p | Malignant pleural mesothelioma | MNDR-E-MI-56593 |
| MNDR | hsa-miR-512-3p | Hodgkin disease | MNDR-E-MI-56594 |
| MNDR | hsa-miR-512-3p | Tonsil cancer | MNDR-E-MI-56595 |
| MNDR | hsa-miR-512-3p | Colorectal cancer | MNDR-E-MI-56596 |
| MNDR | hsa-miR-512-3p | Nasopharynx carcinoma | MNDR-E-MI-56597 |
| MNDR | hsa-miR-512-3p | Multiple myeloma | MNDR-E-MI-56598 |
| MNDR | hsa-miR-512-3p | Nasopharyngeal cancer | MNDR-E-MI-56599 |
| MNDR | hsa-miR-512-3p | Chronic pain | MNDR-E-MI-56600 |
| MNDR | hsa-miR-512-3p | Breast cancer her3+ negative | MNDR-E-MI-56601 |
| MNDR | hsa-miR-512-3p | Solid-pseudopapillary neoplasm of pancreas | MNDR-E-MI-56602 |
RNA Interaction Information
| Resource | RNA Symbol | Species | Link | RNALocate ID |
| RNAInter | CD44 | Homo sapiens | RR00301717 |
TOP